GENEREX BIOTECHNOLOGY CORP — Operating Income by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/05266242-b542-4ef5-bc49-dd7cb7de074c/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-17.9M | 2019-08-01 – 2020-07-31 | evidence 0001607062-20-000327 |
| FY 2019 | $-24.3M | 2018-08-01 – 2019-07-31 | evidence 0001607062-19-000429 |
| FY 2018 | $-2.5M | 2017-08-01 – 2018-07-31 | evidence 0001607062-18-000361 |
| FY 2017 | $-1.6M | 2016-08-01 – 2017-07-31 | evidence 0001607062-17-000349 |
| FY 2016 | $-1.9M | 2015-08-01 – 2016-07-31 | evidence 0001607062-17-000021 |
| FY 2015 | $-3.6M | 2014-08-01 – 2015-07-31 | evidence 0001607062-17-000021 |
| FY 2014 | $-4.4M | 2013-08-01 – 2014-07-31 | evidence 0001607062-14-000128 |
| FY 2013 | $-296.0M | 1996-02-02 – 2014-04-30 | evidence 0001607062-14-000015 |
| FY 2012 | $-290.8M | 1995-11-02 – 2013-04-30 | evidence 0001144204-13-034142 |
| FY 2011 | $-283.9M | 1995-11-02 – 2012-04-30 | evidence 0001144204-12-034225 |
| FY 2010 | $-29.4M | 2009-07-31 – 2010-07-31 | evidence 0001144204-12-056138 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
GENEREX BIOTECHNOLOGY CORP — all facts · Revenue · Net Income